NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

If all they have to talk about is Sawston buildout and asking desperate patients to fork out for an unapproved treatment then the SP will be pounded down. The Sawston buildout should have happened years ago and if they cannot be upfront with a clear path forward to approval of DCVax which we have now been waiting for more than a year then I think this management team will quite rightly be panned. It is unfortunate that we as investors cannot be present and demand answers if they are not forth coming with real trial news.
I am hoping for so much more this time round because if what you suggest is all they will reveal then the departure of KD will signal something very negative to the market and to us long term investors.
The time for this management team to start delivering to its investors is now and I truly hope that is exactly what they do especially after calling for all investors to attend.
I for one cannot be part of questions because the only thing I expect is news on the DCVax-L trial and a clear path forward to approval. Everything else is just a chance for them to deflect.
Every question posed to this management team should not allow for deflection and only be directed at why we have not reached datalock and topline if this is not revealed in the weeks leading up to the ASM.
If we have our answers to this then we need to know what plans the company have with regards action items that blaze a path to approval in all 4 regions.
We as investors need to start seeing positive action that allows all of us and patients to start getting excited that we are finally about to cross the finish line.